They are required to follow cGMP, which is substantially more rigorous than the 503A framework though still not identical to the full apparatus that governs an approved finished drug
Now it sounds reasonable, it sounds intuitive, and it tends to be generally wrong
Compounding is still allowed under certain conditions, such as when a prescriber determines the FDA-approved drug is not suitable for a specific patient
In contrast, prolactin levels within the physiological range, particularly the proposed HomeoFIT-PRL range (approximately 7100 g/L), are associated with more favorable metabolic indicators
Its receptors are expressed in multiple tissues, including the heart, kidneys, lungs, and smooth muscle
This may seem like a small difference, but it greatly impacts the drugs effect on weight and blood sugar control